CYP2D6 and substance abuse: These psychotic symptoms may emerge even at therapeutic doses and are more commonly observed in patients with a history of substance abuse, head trauma, or those taking bupropion in combination with medications metabolized by the cytochrome P450 system, particularly cytochrome P450 2D6 (CYP2D6), which bupropion strongly inhibits.